Latilactobacillus sakei QC9 alleviates hyperglycaemia in high-fat diet and streptozotocin-induced type 2 diabetes mellitus mice via the microbiota–gut–liver axis

Latilactobacillus sakei can alleviate the disorder of glucose and lipid metabolism in T2DM mice through the microbiota–gut–liver axis.